A detailed history of Ewa, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ewa, LLC holds 11,647 shares of RDY stock, worth $162,359. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,647
Previous 11,239 3.63%
Holding current value
$162,359
Previous $169 Million 3.61%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 31, 2025

BUY
$13.33 - $15.08 $5,438 - $6,152
408 Added 3.63%
11,647 $163 Million
Q2 2025

Jul 18, 2025

SELL
$12.36 - $16.17 $2,224 - $2,910
-180 Reduced 1.58%
11,239 $169 Million
Q1 2025

Apr 22, 2025

BUY
$12.53 - $15.81 $5,187 - $6,545
414 Added 3.76%
11,419 $151 Million
Q4 2024

Feb 14, 2025

SELL
$13.99 - $79.75 $4,378 - $24,961
-313 Reduced 2.77%
11,005 $174 Million
Q3 2024

Nov 15, 2024

BUY
$75.41 - $84.21 $853,490 - $953,088
11,318 New
11,318 $161 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.31B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Ewa, LLC Portfolio

Follow Ewa, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ewa, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ewa, LLC with notifications on news.